Company attributes
Industry
Location
B2X
Founder
AngelList URL
Pitchbook URL
Legal Name
Amaryllis Nucleics, Inc.
Accelerator
Accelerator Batch
Legal classification
Date Incorporated
2016
Spun Out From
Number of Employees (Ranges)
1 – 10
Phone Number
+141550832300
Full Address
355 30th St., Oakland, California 94609, US
Place of Incorporation
Founded Date
February 2016
Fax Number
(888) 850-23210
Total Funding Amount (USD)
250,000
Latest Funding Round Date
March 2016
Latest Funding Type
Wellfound ID
Country
Headquarters
Other attributes
Company Operating Status
Active
Related Industries
Amaryllis Nucleics is a spinoff from University of California-Davis. The company aims to democratize RNA sequencing and they are proponents of open science and open-source software. Their method for RNA-seq library synthesis takes advantage of a phenomenon called DNA breathing to capture the 5’ adapter.
Amarlyllis Nucleics is developing sequencing technology for diagnostics and epidemiology. Amaryllis Nucleics is developing a universal viral RNA detection kit that would detect COVID, Influenza, and other viral infections in the same test. The test would also detect and track mutations. The kit will use next-generation sequencing technology on a type of machine that can run thousands of samples per day.
Timeline
No Timeline data yet.
